OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial.
Saved in:
| Title: | OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial. |
|---|---|
| Authors: | Alhelaly M; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Ophthalmology Department, Tanta University, Tanta, Egypt., Soylu C; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California., Oncel D; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California., Corradetti G; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California., Chen K; Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California., Jackson NJ; Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California., Rathinam SR; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India., Gonzales JA; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California., Thundikandy R; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India., Kanakath AV; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Coimbatore, India., Murugan SB; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Pondicherry, India., Vedhanayaki R; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India., Lim LL; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia., Suhler EB; Casey Eye Institute, Oregon Health Science University, Portland, Oregon.; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon., Al-Dhibi HA; Division of Vitreoretinal Surgery and Uveitis, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia., Doan T; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California., Sadda SR; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California., Madow B; Ira G. Ross Eye Institute, Department of Ophthalmology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/State University of New York (SUNY), Buffalo, New York., Coyne AB; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California., Acharya NR; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California., Tsui E; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Ocular Inflammatory Disease Center, UCLA Stein Eye Institute, Los Angeles, California. |
| Source: | Ophthalmology science [Ophthalmol Sci] 2026 Feb 05; Vol. 6 (4), pp. 101106. Date of Electronic Publication: 2026 Feb 05 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier, B.V Country of Publication: Netherlands NLM ID: 9918230896206676 Publication Model: eCollection Cited Medium: Internet ISSN: 2666-9145 (Electronic) Linking ISSN: 26669145 NLM ISO Abbreviation: Ophthalmol Sci Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41853570 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Alhelaly+M%22">Alhelaly M</searchLink>; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Ophthalmology Department, Tanta University, Tanta, Egypt.<br /><searchLink fieldCode="AU" term="%22Soylu+C%22">Soylu C</searchLink>; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Oncel+D%22">Oncel D</searchLink>; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Corradetti+G%22">Corradetti G</searchLink>; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Chen+K%22">Chen K</searchLink>; Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Jackson+NJ%22">Jackson NJ</searchLink>; Division of General Internal Medicine and Health Services Research, Department of Medicine, David Geffen School of Medicine at UCLA, University of California, Los Angeles, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Rathinam+SR%22">Rathinam SR</searchLink>; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India.<br /><searchLink fieldCode="AU" term="%22Gonzales+JA%22">Gonzales JA</searchLink>; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Thundikandy+R%22">Thundikandy R</searchLink>; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India.<br /><searchLink fieldCode="AU" term="%22Kanakath+AV%22">Kanakath AV</searchLink>; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Coimbatore, India.<br /><searchLink fieldCode="AU" term="%22Murugan+SB%22">Murugan SB</searchLink>; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Pondicherry, India.<br /><searchLink fieldCode="AU" term="%22Vedhanayaki+R%22">Vedhanayaki R</searchLink>; Uvea Services, Aravind Eye Hospitals and Postgraduate Institute of Ophthalmology, Madurai, India.<br /><searchLink fieldCode="AU" term="%22Lim+LL%22">Lim LL</searchLink>; Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, East Melbourne, Australia.<br /><searchLink fieldCode="AU" term="%22Suhler+EB%22">Suhler EB</searchLink>; Casey Eye Institute, Oregon Health Science University, Portland, Oregon.; Casey Eye Institute, Oregon Health and Science University, Portland, Oregon.<br /><searchLink fieldCode="AU" term="%22Al-Dhibi+HA%22">Al-Dhibi HA</searchLink>; Division of Vitreoretinal Surgery and Uveitis, King Khaled Eye Specialist Hospital, Riyadh, Kingdom of Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Doan+T%22">Doan T</searchLink>; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Sadda+SR%22">Sadda SR</searchLink>; Department of Ophthalmology, Doheny Eye Institute, Pasadena, California.; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.<br /><searchLink fieldCode="AU" term="%22Madow+B%22">Madow B</searchLink>; Ira G. Ross Eye Institute, Department of Ophthalmology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo/State University of New York (SUNY), Buffalo, New York.<br /><searchLink fieldCode="AU" term="%22Coyne+AB%22">Coyne AB</searchLink>; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Acharya+NR%22">Acharya NR</searchLink>; F.I Proctor Foundation, University of California, San Francisco, San Francisco, California.; Department of Ophthalmology, University of California, San Francisco, San Francisco, California.; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California.<br /><searchLink fieldCode="AU" term="%22Tsui+E%22">Tsui E</searchLink>; Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.; Ocular Inflammatory Disease Center, UCLA Stein Eye Institute, Los Angeles, California. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229918230896206676%22">Ophthalmology science</searchLink> [Ophthalmol Sci] 2026 Feb 05; Vol. 6 (4), pp. 101106. <i>Date of Electronic Publication: </i>2026 Feb 05 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier%2C+B%2EV%22">Elsevier, B.V </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>9918230896206676 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-9145 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226669145%22">26669145 </searchLink><i>NLM ISO Abbreviation: </i>Ophthalmol Sci <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41853570 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.xops.2026.101106 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 101106 Titles: – TitleFull: OCT-Based Evaluation of Vitreous Haze in the First-Line Antimetabolites as Steroid-Sparing Treatment Uveitis Trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Alhelaly M – PersonEntity: Name: NameFull: Soylu C – PersonEntity: Name: NameFull: Oncel D – PersonEntity: Name: NameFull: Corradetti G – PersonEntity: Name: NameFull: Chen K – PersonEntity: Name: NameFull: Jackson NJ – PersonEntity: Name: NameFull: Rathinam SR – PersonEntity: Name: NameFull: Gonzales JA – PersonEntity: Name: NameFull: Thundikandy R – PersonEntity: Name: NameFull: Kanakath AV – PersonEntity: Name: NameFull: Murugan SB – PersonEntity: Name: NameFull: Vedhanayaki R – PersonEntity: Name: NameFull: Lim LL – PersonEntity: Name: NameFull: Suhler EB – PersonEntity: Name: NameFull: Al-Dhibi HA – PersonEntity: Name: NameFull: Doan T – PersonEntity: Name: NameFull: Sadda SR – PersonEntity: Name: NameFull: Madow B – PersonEntity: Name: NameFull: Coyne AB – PersonEntity: Name: NameFull: Acharya NR – PersonEntity: Name: NameFull: Tsui E IsPartOfRelationships: – BibEntity: Dates: – D: 05 M: 02 Text: 2026 Feb 05 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2666-9145 Numbering: – Type: volume Value: 6 – Type: issue Value: 4 Titles: – TitleFull: Ophthalmology science Type: main |
| ResultId | 1 |